Townsquare Capital LLC Sells 536 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Townsquare Capital LLC lowered its position in Stevanato Group S.p.A. (NYSE:STVN) by 1.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,187 shares of the company’s stock after selling 536 shares during the period. Townsquare Capital LLC’s holdings in Stevanato Group were worth $701,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. AMI Asset Management Corp purchased a new stake in Stevanato Group in the 4th quarter valued at about $1,089,000. SG Americas Securities LLC increased its position in shares of Stevanato Group by 18.2% during the fourth quarter. SG Americas Securities LLC now owns 15,546 shares of the company’s stock valued at $339,000 after acquiring an additional 2,389 shares during the last quarter. Jennison Associates LLC bought a new stake in Stevanato Group during the fourth quarter worth $20,239,000. Conestoga Capital Advisors LLC boosted its position in Stevanato Group by 5.3% in the fourth quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company’s stock worth $176,128,000 after purchasing an additional 407,086 shares during the last quarter. Finally, Truist Financial Corp grew its stake in Stevanato Group by 4.2% in the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company’s stock valued at $586,000 after purchasing an additional 1,073 shares during the period.

Stevanato Group Price Performance

Shares of NYSE:STVN opened at €21.88 ($24.93) on Friday. The company has a 50-day moving average price of €20.56 and a two-hundred day moving average price of €20.67. Stevanato Group S.p.A. has a twelve month low of €16.56 ($18.87) and a twelve month high of €29.11 ($33.17). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $6.63 billion, a PE ratio of 46.55, a P/E/G ratio of 7.18 and a beta of 0.52.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.23) EPS for the quarter, hitting the consensus estimate of €0.20 ($0.23). The company had revenue of €352.68 million during the quarter, compared to the consensus estimate of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Equities analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on STVN shares. UBS Group reduced their price target on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research report on Friday, March 7th. William Blair restated an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of €25.70 ($29.29).

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.